TheraPten Biosciences Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2M
Latest Deal Amount
  • Investors
  • 1

TheraPten Biosciences General Information

Description

Provider of pre-clinical biotechnological research and development services intended to develop naturally-occurring anti-cancer therapeutic protein. The company's services are focused on the development of potent tumor suppressor proteins that are functionally inactivated in many human cancers, enabling health workers to find a treatment for cancer-related diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 101-1865 Dilworth Drive
  • Suite 705
  • Kelowna, British Columbia V1Y 9T1
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TheraPten Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 16-Jul-2018 $2M 000 Completed Generating Revenue
To view TheraPten Biosciences’s complete valuation and funding history, request access »

TheraPten Biosciences Patents

TheraPten Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11078497-B2 Compositions and methods to manufacture tumor suppressor fusions Active 12-Apr-2019 000000000 0
US-20210079423-A1 Compositions and methods to manufacture tumor suppressor fusions Granted 12-Apr-2019 00000000

TheraPten Biosciences Executive Team (3)

Name Title Board Seat Contact Info
Nassos Alevizopoulos Ph.D Co-Founder, Chairman & Chief Executive Officer
Harvey Lalach Co-Founder, Director & Chief Business Officer
Ramon Parsons Ph.D Co-Founder & Scientific Advisor
To view TheraPten Biosciences’s complete executive team members history, request access »

TheraPten Biosciences Board Members (3)

Name Representing Role Since
Kyriakoulis Paganis TheraPten Biosciences Board Member 000 0000
Nassos Alevizopoulos Ph.D TheraPten Biosciences Co-Founder, Chairman & Chief Executive Officer 000 0000
Yiannis Monovoukas TheraPten Biosciences Board Member 000 0000
To view TheraPten Biosciences’s complete board members history, request access »

TheraPten Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Columbia Technology Ventures University Minority 000 0000 000000 0
To view TheraPten Biosciences’s complete investors history, request access »